SERKO LIMITED — Director's Dealing 2018

Jul 17, 2018

==> picture [124 x 31] intentionally omitted <==

Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

ToNZX Limited; and
Name of listedissuer:		SerkoLimited (SKO)
Date this disclosuremade:		18-Jul-18
Date of last disclosure:		24-Feb-17
Director or senior manager giving disclosure
Full name(s):		CharlesNowaczek
Name of listedissuer:		SerkoLimited (SKO)
Name of related body corporate (ifapplicable):		SerkoTrusteeLimited
Position held in listed issuer:		Chief Operating Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:		Ordinary Shares in Serko Limited (Ordinary Shares)
Nature of the affected relevant interest(s):		Beneficial interest in Ordinary Shares with restrictive conditions allocated pursuant to the Serko Limited Employee Restricted Share Scheme, held in trust until vesting.
For that relevant interest-
Number held in class before acquisition or disposal:		420,288 Ordinary Shares with restrictive conditions
Number held in class after acquisition or disposal:		454,700 Ordinary Shares with restrictive conditions
Currentregisteredholder(s):		SerkoTrusteeLimited
Registeredholder(s) once transfers areregistered:		SerkoTrusteeLimited
Details of transactions giving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates:		one
Details of transactions requiring disclosure-
Date oftransaction:		6-Jul-18
Nature of transaction:		Allocation of Ordinary Shares, with restrictive conditions, pursuant to the Serko Limited Employee Restricted Share Scheme to Charles Nowczek.
Name of any other party or parties to the transaction (if known):		Serko Trustee Limited is the registered holder of the shares until they vest.
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration:		Ordinary shares allocated as part of Mr Nowaczek's remuneration package, at a value of $2.9594 per share (being the 20 day volume weighted average market price of Ordinary Shares on the NZX Main Board through to 5 July 2018).
Number of financial products to which the transaction related:		34,412 Ordinary Shares with restrictive conditions
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevant interests were acquired or disposed of during a closed period:		No
Whether prior written clearance was provided to allow the acquisition or disposalto proceed during the closed period:		Not Applicable
Date ofthe prior writtenclearance (ifany):		NotApplicable
Summary of other relevant interests after acquisition or disposal:
Class ofquotedfinancialproducts:		NotApplicable
Nature of relevantinterest:
_For that relevant interest,- _
Number heldinclass:
Currentregisteredholder(s):
For a derivative relevant interest,-

Type of derivative:

Not Applicable

- Details of derivative,

The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):

A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable

Not Applicable Not Applicable

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer:

Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

==> picture [152 x 71] intentionally omitted <==

----- Start of picture text -----

18-Jul-2018
----- End of picture text -----